Figures
↓ Figure 1. PRISMA 2020 flow diagram of study selection. Flow diagram showing identification, screening, eligibility assessment, and inclusion of studies evaluating renal tumors in young adults (18–45 years).

↓ Figure 2. Forest plot of pooled proportion of incidental tumor diagnosis. Random-effects generalized linear mixed model (GLMM) estimating the pooled proportion of tumors detected incidentally. Proportions are presented with 95% confidence intervals.

↓ Figure 3. Forest plot of pooled proportion of symptomatic tumor diagnosis. Random-effects GLMM estimating pooled symptomatic presentation rates with 95% confidence intervals.

↓ Figure 4. Forest plot of pooled mean tumor size (cm). Random-effects inverse-variance model showing pooled mean tumor size with 95% confidence intervals. Heterogeneity assessed using I2 and τ2 statistics.

↓ Figure 5. Forest plot of pooled proportion of clear cell histology. Random-effects GLMM estimating prevalence of clear cell renal cell carcinoma among young adults.

↓ Figure 6. Forest plot of pooled proportion of papillary histology. Random-effects GLMM estimating prevalence of papillary renal cell carcinoma.

↓ Figure 7. Forest plot of pooled proportion of chromophobe histology. Random-effects GLMM estimating prevalence of chromophobe renal cell carcinoma.

↓ Figure 8. Forest plot of pooled proportion of tumor recurrence. Random-effects GLMM estimating pooled recurrence rate following treatment.

↓ Figure 9. Forest plot of pooled proportion of overall mortality. Random-effects GLMM estimating pooled mortality rate among included cohorts.

↓ Figure 10. Funnel plot assessing publication bias for clear cell histology. Funnel plot of standard error versus logit-transformed proportion. Symmetry assessed visually.

↓ Figure 11. Funnel plot assessing publication bias for papillary histology. Standard error plotted against logit-transformed pooled proportions.

↓ Figure 12. Funnel plot assessing publication bias for chromophobe histology. Visual assessment of small-study effects.

↓ Figure 13. Funnel plot assessing publication bias for overall mortality. Standard error plotted against logit-transformed pooled proportions.

Table
↓ Table 1. Risk of Bias Assessment of Included Studies Using the Newcastle–Ottawa Scale (NOS)
| Study | Selection | Comparability | Outcome | Overall NOS |
|---|
| The figure presents domain-specific star ratings for selection (max 4), comparability (max 2), and outcome (max 3) across 16 studies on renal tumors in young adults. Overall scores range from 0 to 9, with risk of bias categorized as low (7–9 stars), moderate (4–6 stars), or serious (0–3 stars). Higher scores indicate lower risk of bias. |
| Abou El Fettouh et al, 2002 [7] | ★★☆☆ | ☆☆ | ★★☆ | 4 |
| Akhavan et al, 2015 [3] | ★★★★ | ★★ | ★★★ | 9 |
| Aslan et al, 2018 [9] | ★★☆☆ | ☆☆ | ★★★ | 5 |
| Aziz et al, 2014 [13] | ★★★★ | ★★ | ★★★ | 9 |
| Cakici et al, 2020 [8] | ★★★★ | ★★ | ★★★ | 9 |
| Clemmensen et al, 2018 [17] | ★★☆☆ | ★☆ | ★★★ | 6 |
| Eggener et al, 2004 [10] | ★★☆☆ | ☆☆ | ★★☆ | 4 |
| King et al, 2014 [15] | ★★★★ | ★☆ | ★★★ | 8 |
| Lopez et al, 2010 [12] | ★★☆☆ | ☆☆ | ★★☆ | 4 |
| Mohsin et al, 2012 [11] | ★★☆☆ | ☆☆ | ★★☆ | 4 |
| Nayyar et al, 2022 [1] | ★★★☆ | ★★ | ★★★ | 8 |
| Palumbo et al, 2020 [16] | ★★★★ | ★★ | ★★★ | 9 |
| Siemer et al, 2006 [4] | ★★★☆ | ★☆ | ★★★ | 7 |
| Taccoen et al, 2007 [5] | ★★★☆ | ★☆ | ★★☆ | 6 |
| Xu et al, 2015 [14] | ★★★☆ | ★☆ | ★★★ | 7 |
| Xue et al, 2024 [6] | ★★★★ | ★★ | ★★★ | 9 |